BackScopus Biopharma Overview

Scopus Biopharma Current Cash

Latest current cash for SCPS: $360K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$362097.00
↓ 68.69% YoYΔ $-794368.00 vs prior year quarter

Peer average

Loading

Scopus Biopharma Current Cash History

Loading

Scopus Biopharma vs. peers: Current Cash Comparison

Loading

Scopus Biopharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Scopus Biopharma (SCPS) FAQ

Scopus Biopharma (SCPS) currently reports a current cash of $360K as of June 2023. That compares with $1.2M in the prior-year period — down 68.7% year over year. Use the charts on this page to explore Scopus Biopharma's current cash history and peer comparisons.

Scopus Biopharma's current cash decreased from $1.2M to $360K — a 68.7% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Scopus Biopharma reported $360K in current cash as of June 2023. That compares with $1.2M in the prior-year period — down 68.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $360K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Scopus Biopharma, and consider following SCPS for alerts when major investors trade the stock.

Scopus Biopharma is classified in the Healthcare sector. On current cash, it currently shows $360K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SCPS with unrelated industries.